Table 3.
PTEN scoring agreement for endometrioid (n=84) vs non-endometrioid (n=34) cases in the study set following independent performance of immunohistochemistry and scoring at MSKCC and MDACC.
| Non-endometrioid | Endometrioid | |||||
|---|---|---|---|---|---|---|
| MDACC | ||||||
| MSKCC | Neg. | Het. | Pos. | Neg. | Het. | Pos. |
| Negative | 4 | 1 | 1 | 39 | 8 | 1 |
| Heterogeneous | 0 | 4 | 1 | 1 | 9 | 2 |
| Positive | 0 | 2 | 21 | 0 | 4 | 20 |
| Weighted κ (95% CI) | 0.74 (0.52–0.96) | 0.78 (0.67–0.88) | ||||
| Percent Agreement (95% CI) | 81% (71–89%) | 85% (69%–95%) | ||||